GLPs reduce breast cancer, derms beat AI, PrEP underused, and fewer unnecessary antibiotics

Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity

Two observational studies found that GLP-1 receptor agonists (like Ozempic, Wegovy) are associated with reduced breast cancer incidence in w

Should You Overhaul Your Skin Care Routine If You’re on a GLP-1?

Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients

A study analyzing over 6,800 colon cancer patients across University of California Health sites found that patients taking GLP-1 medications

Impact of GLP-1s on Life Insurance and Insights from a Health Tech Event

The article discusses the impact of GLP-1s on life insurance and shares insights from a health tech event in Amsterdam. It also highlights t

Could Ozempic Lower Breast Cancer Risk? What to Know

Stewardship / Resistance Scan for Mar 18, 2019